10/30
02:18 pm
ions
Rating for IONS
Low
Report
Rating for IONS
10/30
02:18 pm
ions
Rating for IONS
Low
Report
Rating for IONS
10/30
12:18 pm
ions
Rating for IONS
Low
Report
Rating for IONS
10/30
12:18 pm
ions
Rating for IONS
Low
Report
Rating for IONS
10/30
11:17 am
ions
Rating for IONS
Low
Report
Rating for IONS
10/30
11:17 am
ions
Rating for IONS
Low
Report
Rating for IONS
10/30
11:02 am
ions
Ionis Pharmaceuticals (NASDAQ:IONS) had its "strong-buy" rating reaffirmed by analysts at Raymond James Financial, Inc.. They now have a $89.00 price target on the stock, up previously from $85.00.
Low
Report
Ionis Pharmaceuticals (NASDAQ:IONS) had its "strong-buy" rating reaffirmed by analysts at Raymond James Financial, Inc.. They now have a $89.00 price target on the stock, up previously from $85.00.
10/30
10:59 am
ions
Ionis Pharmaceuticals (NASDAQ:IONS) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Low
Report
Ionis Pharmaceuticals (NASDAQ:IONS) had its "buy" rating reaffirmed by analysts at HC Wainwright.
10/30
10:59 am
ions
Rating for IONS
Low
Report
Rating for IONS
10/30
10:59 am
ions
Rating for IONS
Low
Report
Rating for IONS
10/30
08:13 am
ions
Ionis Pharmaceuticals (NASDAQ:IONS) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
Low
Report
Ionis Pharmaceuticals (NASDAQ:IONS) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
10/30
06:13 am
ions
Rating for IONS
Medium
Report
Rating for IONS
10/30
06:13 am
ions
Rating for IONS
Medium
Report
Rating for IONS
10/16
01:56 pm
ions
Rating for IONS
Low
Report
Rating for IONS
10/16
01:56 pm
ions
Rating for IONS
Low
Report
Rating for IONS
10/8
12:23 pm
ions
Rating for IONS
Low
Report
Rating for IONS
10/8
12:23 pm
ions
Rating for IONS
Low
Report
Rating for IONS
10/8
11:48 am
ions
Rating for IONS
Low
Report
Rating for IONS
10/8
11:48 am
ions
Rating for IONS
Low
Report
Rating for IONS
10/8
08:20 am
ions
Ionis Pharmaceuticals (NASDAQ:IONS) had its "outperform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc..
Low
Report
Ionis Pharmaceuticals (NASDAQ:IONS) had its "outperform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc..
10/8
08:09 am
ions
Ionis Pharmaceuticals (NASDAQ:IONS) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $95.00 price target on the stock.
Low
Report
Ionis Pharmaceuticals (NASDAQ:IONS) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $95.00 price target on the stock.
10/8
08:09 am
ions
Ionis Pharmaceuticals (NASDAQ:IONS) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $80.00 price target on the stock, up previously from $49.00.
Low
Report
Ionis Pharmaceuticals (NASDAQ:IONS) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $80.00 price target on the stock, up previously from $49.00.
10/8
07:46 am
ions
Rating for IONS
Low
Report
Rating for IONS
10/8
04:41 am
ions
Ionis Pharmaceuticals upgraded to Overweight from Neutral at JPMorgan
Low
Report
Ionis Pharmaceuticals upgraded to Overweight from Neutral at JPMorgan
10/6
08:22 am
ions
Rating for IONS
Low
Report
Rating for IONS